Abbott Labs (NYSE:ABT) is set to report its Q3 2018 earnings on October 17, and we expect the company to post steady growth, led by its Diagnostics and Medical Devices segments. While the Diagnostics business will likely benefit from market share gains in core laboratory, the Medical Devices...
Abbott Labs (NYSE:ABT) is set to report its Q3 2018 earnings on October 17, and we expect the company to post steady growth, led by its Diagnostics and Medical Devices segments. While the Diagnostics business will likely benefit from market share gains in core laboratory, the Medical Devices...
Share this Article
Recommended